We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
+0.4%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$104B
AUM Growth
+$9.45B
Cap. Flow
+$9.9B
Cap. Flow %
9.52%
Top 10 Hldgs %
28.08%
Holding
8,130
New
449
Increased
3,536
Reduced
3,324
Closed
388

Sector Composition

Rank Sector Weight
1 Healthcare 5.43%
2 Energy 4.72%
3 Technology 4.42%
4 Financials 3.4%
5 Consumer Discretionary 3.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VVX icon
7251
PUT
V2X
VVX
$2.65B
$2K ﹤0.01%
+100
New +$1.96K
WIX icon
7252
WIX.com
WIX
$2.52B
$2K ﹤0.01%
144
-110
-43% -$1.92K
WIT icon
7253
Wipro
WIT
$20B
$2K ﹤0.01%
1,067
-533
-33% -$1.19K
WULF icon
7254
TeraWulf
WULF
$8.52B
$2K ﹤0.01%
+100
New +$2.12K
RVNC
7255
DELISTED
Revance Therapeutics, Inc.
RVNC
$2K ﹤0.01%
111
-1,868
-94% -$48.7K
ASXC
7256
DELISTED
Asensus Surgical, Inc.
ASXC
$2K ﹤0.01%
39
-9
-19% -$485
SCX
7257
DELISTED
The L.S. Starrett Company
SCX
$2K ﹤0.01%
170
+103
+154% +$1.62K
TTOO
7258
DELISTED
T2 Biosystems, Inc
TTOO
0
BPTH
7259
DELISTED
Bio-Path Holdings Inc
BPTH
0
SRC
7260
CALL
DELISTED
SPIRIT REALTY CAPITAL, INC.
SRC
$2K ﹤0.01%
+45
New +$2.33K
LOV
7261
DELISTED
Spark Networks SE American Depositary Shares
LOV
$2K ﹤0.01%
379
-1,088
-74% -$5.86K
ABMD
7262
CALL
DELISTED
Abiomed Inc
ABMD
$2K ﹤0.01%
100
SUNS
7263
DELISTED
SLR Senior Investment Corp. Common Stock
SUNS
$2K ﹤0.01%
141
+117
+488% +$1.89K
CSLT
7264
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$2K ﹤0.01%
134
-150
-53% -$1.98K
CVA
7265
CALL
DELISTED
Covanta Holding Corporation
CVA
$2K ﹤0.01%
+100
New +$2.08K
CVA
7266
PUT
DELISTED
Covanta Holding Corporation
CVA
$2K ﹤0.01%
+100
New +$2.08K
CLCT
7267
DELISTED
Collectors Universe
CLCT
$2K ﹤0.01%
72
-79
-52% -$1.6K
CBL
7268
PUT
DELISTED
CBL& Associates Properties, Inc.
CBL
$2K ﹤0.01%
+100
New +$1.89K
CETV
7269
PUT
DELISTED
Central European Media Enterprises Ltd
CETV
$2K ﹤0.01%
1,100
AFH
7270
DELISTED
Atlas Financial Holdings, Inc. Ordinary Shares
AFH
$2K ﹤0.01%
120
-132
-52% -$1.87K
BGG
7271
PUT
DELISTED
Briggs & Stratton Corp.
BGG
$2K ﹤0.01%
100
-1,100
-92% -$21.5K
CRCM
7272
DELISTED
CARE.COM, INC.
CRCM
$2K ﹤0.01%
216
+37
+21% +$352
UCFC
7273
DELISTED
United Community Financial Corp
UCFC
$2K ﹤0.01%
526
-384
-42% -$1.69K
DEST
7274
DELISTED
Destination Maternity Corporation
DEST
$2K ﹤0.01%
163
-5,697
-97% -$114K
ADYX
7275
DELISTED
Adynxx Inc
ADYX
$2K ﹤0.01%
+8
New +$2.56K

Similar funds

Barclays's Q3 2014 Portfolio in Review

As of Q3 2014, Barclays held 8,130 positions worth $104B, up 10% from $94.6B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Barclays deployed $9.9B of net new capital in Q3 2014, opening 449 new positions and adding to 3,536 existing holdings. Its largest new stake was ICL Group: 10,685,387 shares worth $74.8M.

By sector, the portfolio is most concentrated in Healthcare at 5.4% of assets, up from 4.9% a quarter earlier, followed by Energy and Technology.

On the sell side, the largest reduction was Phillips 66, an estimated $441M trimmed.

  • Barclays's largest Q3 2014 buy was ICL Group: 10,685,387 shares worth $74.8M.
  • Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2014, an estimated $659M increase.
  • Barclays's biggest Q3 2014 reduction was Phillips 66, cutting an estimated $441M.
  • Barclays fully exited QUESTCOR PHARMA INC in Q3 2014, selling an estimated $87.3M.
  • Barclays's ten largest holdings make up 28% of its $104B portfolio in Q3 2014.
  • Barclays opened 449 new positions and closed 388 in Q3 2014.
  • Barclays's portfolio value rose 10% quarter-over-quarter to $104B.

Based on Barclays's 13F filing for Q3 2014, filed 14 Nov 2014.